Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. (2016)

First Author: Marina NM
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(16)30214-5

PubMed Identifier: 27569442

Publication URI: http://europepmc.org/abstract/MED/27569442

Type: Journal Article/Review

Volume: 17

Parent Publication: The Lancet. Oncology

Issue: 10

ISSN: 1470-2045